Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • SPYM vs MRNA✓SelectedUSD · MRNASPYM vs MRNA performance historyLatest closeAs of-3.55%11/20
Stock and ETF performance explorer

SPYM vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+7.0%
MRNA return
+697.5%
Excess return
-690.5%
Maximum drawdown
-11.4%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 1y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-3.5%-2.2%-1.4%-3.5%
7D-8.4%-12.7%+4.3%-8.3%
30D-10.7%-20.7%+10.0%-10.5%
3M-9.2%+46.3%-55.5%-9.5%
6M-6.4%+305.2%-311.6%-9.7%
YTD+2.1%+561.2%-559.1%-3.8%
1Y+7.0%+772.1%-765.1%-2.2%
All+7.0%+697.5%-690.5%-2.2%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 1y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

1y analysis · Full analysis span regression · 6 months rolling